Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

The ORIGIN Trial Investigators Hamilton, Ontario, Canada

Research output: Contribution to journalArticlepeer-review

138 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)'. Together they form a unique fingerprint.

Medicine & Life Sciences